2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 145 filers reported holding 2SEVENTY BIO INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7 | 0.0% | 1,763 | +35.8% | 0.00% | – |
| Q1 2024 | $7 | -58.8% | 1,298 | -67.4% | 0.00% | – |
| Q4 2023 | $17 | 0.0% | 3,986 | -8.8% | 0.00% | – |
| Q3 2023 | $17 | -61.4% | 4,372 | 0.0% | 0.00% | – |
| Q2 2023 | $44 | +12.8% | 4,372 | +13.0% | 0.00% | – |
| Q1 2023 | $39 | -11.4% | 3,869 | -18.3% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 4,734 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $69,000 | +11.3% | 4,734 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $62,000 | +34.8% | 4,734 | +73.9% | 0.00% | – |
| Q1 2022 | $46,000 | – | 2,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |